| Bioactivity | DNDI-6174 is a cytochrome bc1 complex inhibitor with potent in vitro activity against a variety of Leishmania species. DNDI-6174 can reduce parasite burden in animal models of infection[1]. |
| Name | DNDI-6174 |
| CAS | 2868298-43-3 |
| Formula | C16H13N5O2 |
| Molar Mass | 307.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Stéphanie Braillard, et al. DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1. Sci Transl Med. 2023 Dec 13;15(726):eadh9902. |
DNDI-6174
CAS: 2868298-43-3 F: C16H13N5O2 W: 307.31
DNDI-6174 is a cytochrome bc1 complex inhibitor with potent in vitro activity against a variety of Leishmania species. D
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.